Joel Greenblatt Pfizer Inc Transaction History

Gotham Asset Management, LLC

$7.56 Billion
Q2 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Pfizer Inc stock. As of the latest transaction made, Gotham Asset Management, LLC holds 25,476 shares of PFE stock, worth $745,682. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,476

Previous 33,690 24.38%

Holding current value

$745,682

Previous $934,000 23.77%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $207,485 - $243,134	-8,214 Reduced 24.38%	25,476 $712,000
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $693,541 - $796,407	-26,788 Reduced 44.29%	33,690 $934,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $12.1 Million - $15.7 Million	-462,443 Reduced 88.43%	60,478 $1.74 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $297,378 - $347,605	-9,267 Reduced 1.74%	522,921 $17.3 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $2.85 Million - $3.3 Million	78,965 Added 17.42%	532,188 $19.5 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $7.27 Million - $9.46 Million	184,535 Added 68.68%	453,223 $18.5 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $2.47 Million - $3.22 Million	-59,149 Reduced 18.04%	268,688 $13.8 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $298,399 - $364,270	6,819 Added 2.12%	327,837 $14.3 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $1.38 Million - $1.64 Million	29,725 Added 10.2%	321,018 $16.8 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $3.76 Million - $4.66 Million	-82,192 Reduced 22.01%	291,293 $15.1 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $6.56 Million - $9.72 Million	-158,691 Reduced 29.82%	373,485 $22.1 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $2.16 Million - $2.77 Million	54,946 Added 11.51%	532,176 $22.9 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $409,697 - $464,118	-11,409 Reduced 2.33%	477,230 $18.7 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $1.12 Million - $1.27 Million	-33,529 Reduced 6.42%	488,639 $17.7 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $407,664 - $518,380	12,180 Added 2.39%	522,168 $19.2 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $13.4 Million - $15.7 Million	-421,369 Reduced 45.24%	509,988 $18.7 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $2.39 Million - $2.9 Million	-79,258 Reduced 7.84%	931,357 $30.5 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $5.32 Million - $7.6 Million	196,870 Added 24.19%	1,010,615 $33 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $26.5 Million - $30.1 Million	805,654 Added 9957.41%	813,745 $31.9 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $13.1 Million - $17 Million	-403,692 Reduced 98.04%	8,091 $291,000
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $39.4 Million - $44.2 Million	-1,064,788 Reduced 72.11%	411,783 $17.8 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $33.1 Million - $36.3 Million	882,130 Added 148.4%	1,476,571 $62.7 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $5.42 Million - $6.18 Million	140,800 Added 31.04%	594,441 $25.9 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $28.3 Million - $34.3 Million	-819,658 Reduced 64.37%	453,641 $20 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $4.64 Million - $4.95 Million	-140,811 Reduced 9.96%	1,273,299 $46.2 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $43.5 Million - $50.5 Million	1,364,188 Added 2732.64%	1,414,110 $50.2 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $934,772 - $991,825	28,105 Added 128.82%	49,922 $1.81 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $676,327 - $745,050	21,817	21,817 $779,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $164B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account